-----Original Message-----
From: Fran Griffin of the Fitzgerald Griffin Foundation <publishing@fgfbooks.com>
To: add1dda@aol.com
Sent: Mon, Jun 13, 2022 9:30 a.m.
From: Fran Griffin of the Fitzgerald Griffin Foundation <publishing@fgfbooks.com>
To: add1dda@aol.com
Sent: Mon, Jun 13, 2022 9:30 a.m.
FGF to join Missouri v Biden case:
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
2 comments:
FGF--is that similar to FJB--except insert George floyd,instead of Biden?
Asking for an autistic friend.
--GRA
UNNECESSARY VAXXES FOR KIDS READY FOR INJECTION
WASHINGTON (AP) — Federal health officials said Sunday that kid-sizes doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under 5, a key step toward a long-awaited decision to begin vaccinating the youngest American children.
The Food and Drug Administration posted its analysis of the Pfizer shot ahead of a Wednesday meeting where outside experts will vote on whether the shots are ready for the nation’s 18 million babies, toddlers and preschoolers. Kids under 5 are the only group not yet eligible for COVID-19 vaccination in the U.S.
Late last week the FDA posted a similar analysis of Moderna’s shots for children under 6.
If regulators clear the shots by one or both companies, vaccinations could begin as soon as next week with the drugmakers ready to rapidly ship doses ordered by the government. Parents have been pressing federal officials for months for the opportunity to protect their smallest children as more adults shed masks and abandon other public health precautions.
(GRA:Is that fabrication possibly true? Parents are clamoring for vaxxes for their just born kids?)
While only about 3% of U.S. COVID cases are in the age group 6 months to 4 years, hospitalization and death rates in that group are higher than those for older children, according to the FDA’s analysis — one reason experts have said protecting this group is important.
GRA:None of that paragraph made any sense.If true,why vaxx "older children then?"That's called having it both ways--which the drug companies also call--DOUBLE OUR PROFITS.
--GRA
Post a Comment